Redwood City, CA, United States of America

Gert Kiss

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 10.6

ph-index = 3

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations of Gert Kiss: A Pioneer in SHP2 and mTOR Inhibitors

Introduction: Gert Kiss is an innovative inventor based in Redwood City, California, renowned for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of eight patents, Kiss has been at the forefront of research and development in the area of allosteric inhibitors and mTOR inhibitors. His work has the potential to address various diseases mediated by specific cellular pathways.

Latest Patents: Among Gert Kiss's latest contributions are two groundbreaking patents. The first patent focuses on "Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors." This work outlines novel inhibitors of SHP2 that hold promise for therapeutic applications. The second patent involves "C26-linked rapamycin analogs as mTOR inhibitors." This disclosure pertains to the synthesis and application of compounds aimed at inhibiting mTOR, with implications for treating diseases associated with this critical pathway.

Career Highlights: Gert Kiss is currently affiliated with Revolution Medicines, Inc., a leading biopharmaceutical company focused on the development of targeted medicines for cancer patients. His research efforts and innovative mindset have played a vital role in advancing the company's mission to explore new avenues in cancer treatment.

Collaborations: Throughout his career, Gert Kiss has collaborated with talented professionals in the industry, including colleagues Adrian L. Gill and Christopher Michael Semko. These collaborations have fostered a dynamic environment for research and innovation, leading to the development of unique solutions in the pharmaceutical space.

Conclusion: Gert Kiss exemplifies the spirit of innovation in the realm of pharmaceutical research and development. With an impressive number of patents and a focus on breakthrough therapies, he stands as a key figure in the fight against diseases impacted by SHP2 and mTOR pathways. His work at Revolution Medicines, Inc. signals a commitment to advancing science and improving patient outcomes through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…